These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 31848062)
1. The Use of Inhaled N-Acetylcysteine for Laryngopharyngeal Reflux Disease: A Randomized Controlled Trial. Jo YS; Choi IS; So YK J Voice; 2021 Jul; 35(4):618-624. PubMed ID: 31848062 [TBL] [Abstract][Full Text] [Related]
2. A Prospective Randomized Clinical Trial of Combination Therapy with Proton Pump Inhibitors and Mucolytics in Patients with Laryngopharyngeal Reflux. Chae M; Jang DH; Kim HC; Kwon M Ann Otol Rhinol Laryngol; 2020 Aug; 129(8):781-787. PubMed ID: 32186395 [TBL] [Abstract][Full Text] [Related]
3. Reflux finding score and reflux symptom index as potential predictors for proton pump inhibitor response in globus pharyngeus patients: A prospective study. Boom L; Edens M; Rinia B Auris Nasus Larynx; 2020 Aug; 47(4):609-615. PubMed ID: 32113831 [TBL] [Abstract][Full Text] [Related]
4. Influence of age on treatment with proton pump inhibitors in patients with laryngopharyngeal reflux disease: a prospective multicenter study. Lee YC; Lee JS; Kim SW; Kwon KH; Eun YG JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1291-5. PubMed ID: 24201320 [TBL] [Abstract][Full Text] [Related]
5. Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial. Pizzorni N; Ambrogi F; Eplite A; Rama S; Robotti C; Lechien J; Schindler A Eur Arch Otorhinolaryngol; 2022 May; 279(5):2533-2542. PubMed ID: 35032204 [TBL] [Abstract][Full Text] [Related]
6. Prospective, observational study using rabeprazole in 455 patients with laryngopharyngeal reflux disease. Lee YS; Choi SH; Son YI; Park YH; Kim SY; Nam SY Eur Arch Otorhinolaryngol; 2011 Jun; 268(6):863-9. PubMed ID: 21221621 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of three proton-pump inhibitor therapeutic strategies on laryngopharyngeal reflux disease; a prospective randomized double-blind study. Yoon YH; Park KW; Lee SH; Park HS; Chang JW; Koo BS Clin Otolaryngol; 2019 Jul; 44(4):612-618. PubMed ID: 31002475 [TBL] [Abstract][Full Text] [Related]
8. LPR: how different diagnostic tools shape the outcomes of treatment. Wan Y; Yan Y; Ma F; Wang L; Lu P; Maytag A; Jiang JJ J Voice; 2014 May; 28(3):362-8. PubMed ID: 24491501 [TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of Proton Pump Inhibitors in the Treatment of Pharyngeal Reflux Disease. Jin X; Zhou X; Fan Z; Qin Y; Zhan J Comput Math Methods Med; 2022; 2022():9105814. PubMed ID: 35912160 [TBL] [Abstract][Full Text] [Related]
10. Relationship between extralaryngeal endoscopic findings, proton pump inhibitor (PPI) response, and pH measures in suspected laryngopharyngeal reflux. Agrawal N; Yadlapati R; Shabeeb N; Price CP; Lidder A; Shintani-Smith S; Bové M; Pandolfino J; Tan B Dis Esophagus; 2019 Apr; 32(4):. PubMed ID: 30101358 [TBL] [Abstract][Full Text] [Related]
12. Nissen fundoplication Zhang C; Hu ZW; Yan C; Wu Q; Wu JM; Du X; Liu DG; Luo T; Li F; Wang ZG World J Gastroenterol; 2017 May; 23(19):3546-3555. PubMed ID: 28596691 [TBL] [Abstract][Full Text] [Related]
13. Transcutaneous electrical acupoint stimulation for suspected laryngopharyngeal reflux disease. Shen H; Han Y; Yao C; Tao Y; Wu J; Gao C; Wu F; Liu Y Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1815-1825. PubMed ID: 36239783 [TBL] [Abstract][Full Text] [Related]
14. An Open Label, Prospective, Single Centre Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Rabeprazole (Enteric-Coated, EC) 20 mg + Domperidone (Sustained Release, SR) 30 mg Capsule in Treatment of Patients with Laryngopharyngeal Reflux Disease. Semmanaselvan K; Mukaddam QI; Naik M J Assoc Physicians India; 2015 Jul; 63(7):27-32. PubMed ID: 26731824 [TBL] [Abstract][Full Text] [Related]
15. Trial of transcutaneous electrical acupoint stimulation in laryngopharyngeal reflux disease: study protocol for a randomized controlled trial. Shen H; Han Y; Wu D; Hu L; Ma Y; Wu F; Tao Y; Liu Y Trials; 2022 Apr; 23(1):272. PubMed ID: 35395946 [TBL] [Abstract][Full Text] [Related]
16. Weaning of proton pump inhibitors in patients with suspected laryngopharyngeal reflux disease. Lin RJ; Sridharan S; Smith LJ; Young VN; Rosen CA Laryngoscope; 2018 Jan; 128(1):133-137. PubMed ID: 28730666 [TBL] [Abstract][Full Text] [Related]
17. Gaviscon® Advance alone versus co-prescription of Gaviscon® Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux. Wilkie MD; Fraser HM; Raja H Eur Arch Otorhinolaryngol; 2018 Oct; 275(10):2515-2521. PubMed ID: 30062580 [TBL] [Abstract][Full Text] [Related]
18. Tonghua Liyan granules in the treatment of Laryngopharyngeal reflux disease with stagnation of phlegm and qi syndrome: a randomized, double-blind, placebo-controlled study. Li Y; Zheng M; Wang Y; Xu G; He Y; Wu Y; Wang X; Liu Y; Jiang Y; Liu X; Meng Y; Yap Y; Zhu S; He C; Zhou B Front Pharmacol; 2024; 15():1275740. PubMed ID: 38464723 [No Abstract] [Full Text] [Related]
19. Is Adjunctive Alginate Therapy Beneficial in the Treatment of Laryngopharyngeal Reflux Disease in a Rural Indian Population? A Prospective Randomized Study. Mathew AS; Shilpa H Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2104-2110. PubMed ID: 36452699 [TBL] [Abstract][Full Text] [Related]
20. Laryngopharyngeal reflux: Comparing improvements in reflux symptom index with reflux finding score. Hutnik R; Zlatopolsky A; Mehraban-Far S; Alrassi J; McMillan N; Amadi C; Fujita K; Mortensen M Am J Otolaryngol; 2020; 41(6):102730. PubMed ID: 32956939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]